1-(5-isoquinolinesulfonyl)-2-methylpiperazine has been researched along with metoprolol in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Curry, PL; Gao, L; Haack, KK; Pellegrino, PR; Schiller, AM; Zucker, IH | 1 |
1 other study(ies) available for 1-(5-isoquinolinesulfonyl)-2-methylpiperazine and metoprolol
Article | Year |
---|---|
Central Rho kinase inhibition restores baroreflex sensitivity and angiotensin II type 1 receptor protein imbalance in conscious rabbits with chronic heart failure.
Topics: 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine; Animals; Baroreflex; Brain Stem; Chronic Disease; Consciousness; Enzyme Inhibitors; Heart; Heart Failure; Heart Rate; Male; Metoprolol; NG-Nitroarginine Methyl Ester; Nitric Oxide Synthase; Nitroprusside; Phenylephrine; Rabbits; Receptor, Angiotensin, Type 1; rho-Associated Kinases; Sympathetic Nervous System; Vagus Nerve | 2013 |